– December 1, 2013
December 1, 2013
View Archives Issues
-
Bone Mineral Density after Oophorectomy and Tamoxifen in Premenopausal Breast Cancer
In a study conducted as an adjunct to a randomized, Phase 3 investigation of optimal timing of oophorectomy for premenopausal breast cancer patients, Love and colleagues examined changes in bone mineral density (BMD) for patients receiving surgery (oophorectomy and mastectomy) plus tamoxifen. -
Comparison of Two Chemotherapy Regimens for Malignant Pleural Mesothelioma
-
Treatment of ALL in the Elderly
Experience treating acute lymphoblastic leukemia in the elderly using pediatric full-dose regimens has met with high rates of toxicity and induction-related mortality. -
Cetuximab-Gemcitabine for Cholangiocarcinoma: The Belgian Experience
In a multicenter Phase 2 trial, cetuximab combined with gemcitabine resulted in a progression-free survival rate of 47% at 6 months and median overall survival of 13.5 months. -
Cancer Survivorship The Marriage Effect?
Compared to cancer patients who were never married, divorced, widowed, or separated, married patients are significantly more likely to present at an earlier stage, undergo therapy with definitive or curative intent, and live longer among each of the 10 most common cancers killers in the United States. -
Continuing Education Questions